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ABSTRACT
Objectives: To assess the clinical effectiveness of
thigh length versus knee length antiembolism
stockings for the prevention of deep vein thrombosis
(DVT) in surgical patients.
Design: Systematic review and meta-analysis using
direct methods and network meta-analysis.
Methods: Previous systematic reviews and
electronic databases were searched to February 2014
for randomised controlled trials (RCTs) of thigh
length or knee length antiembolism stockings in
surgical patients. Study quality was assessed using
the Cochrane Risk of Bias Tool. The primary
outcome was incidence of DVT. Analysis of the DVT
data was performed using ORs along with 95% CIs.
The I2 statistic was used to quantify statistical
heterogeneity.
Results: 23 RCTs were included; there was
substantial variation between the trials and many were
poorly reported with an unclear risk of bias. Five RCTs
directly comparing thigh length versus knee length
stockings were pooled and the summary estimate of
effect favouring thigh length stockings was not
statistically significant (OR 1.48, 95% CI 0.80 to 2.73).
13 RCTs were included in the network meta-analysis;
thigh length stockings with pharmacological
prophylaxis were more effective than knee length
stockings with pharmacological prophylaxis, but again
results were not statistically significant (OR 1.76, 95%
credible intervals 0.82 to 3.53).
Conclusions: Thigh length stockings may be more
effective than knee length stockings, but results did
not reach statistical significance and the evidence base
is weak. Further research to confirm this finding is
unlikely to be worthwhile. While thigh length stockings
appear to have superior efficacy, practical issues such
as patient acceptability may prevent their wide use in
clinical practice.
Systematic review registration number:
CRD42014007202.
INTRODUCTION
Deep vein thrombosis (DVT) is a condition in
which a blood clot forms in one of the deep
veins of the body, usually in the leg. An emboli
is formed if the blood clot or part of the blood
clot detaches and travels through the venous
system. If the clot lodges in the lung, this is
termed a pulmonary embolism (PE) and this
may be fatal. DVT and PE are collectively
known as venous thromboembolism (VTE).
The House of Commons Health Committee
reported in 2005 that an estimated 25 000
people in the UK die each year from poten-
tially preventable hospital-acquired VTE.1
Surgical patients are at an increased risk of
developing DVT, due to stasis in venous
blood ﬂow and increased coagulability of the
Strengths and limitations of this study
▪ This systematic review used all the available ran-
domised evidence on thigh length or knee length
antiembolism stockings to indirectly compare the
two stocking lengths.
▪ Many trials were old and poorly reported and
there was substantial variation in terms of patient
characteristics and interventions used.
▪ Standard meta-analysis and network
meta-analysis were undertaken in order to
compare all relevant treatments with one
another.
▪ The results of the network meta-analysis were
consistent with the direct meta-analysis,
although there was significant statistical hetero-
geneity in the models.
▪ The uncertain quality of many of the included
trials reduces the reliability of the results of the
review.
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blood, caused by factors such as immobilisation,
decreased ﬂuid intake and blood or body ﬂuid loss. It
has been estimated that between 45 and 51% of patients
undergoing orthopaedic surgery develop DVT, if not
provided with adequate prophylaxis.1 Routine prophy-
laxis reduces morbidity, mortality and health service
costs in patients at risk.2 Prophylaxis can be pharmaco-
logical (such as low-molecular-weight heparin (LMWH))
and/or mechanical (such as antiembolism stockings
(also known as graduated compression stockings)).
Antiembolism stockings are available as thigh length
or knee length stockings. They exert graded pressure at
a decreasing gradient from the ankle towards the thigh
or knee, which increases blood ﬂow velocity and pro-
motes venous return. Patients have reported that both
thigh length and knee length stockings are difﬁcult to
use, but fewer patients reported discomfort with knee
length stockings and patients are more likely to wear
knee length stockings correctly.3–5
The National Institute for Health and Care Excellence
(NICE) guideline ‘Venous thromboembolism: reducing
the risk’ (CG92) states that the length of stockings is a
controversial issue and there is no clear randomised evi-
dence that one length is more effective than another.6
The Scottish Intercollegiate Guidelines Network (SIGN)
guideline on the prevention and management of VTE
(SIGN guideline 122) states that studies comparing
above-knee with below-knee stockings have been too
small to determine whether or not they are equally
effective.2
This systematic review aims to address this question
more deﬁnitively by utilising all the available rando-
mised evidence on thigh length or knee length stock-
ings, rather than just trials that directly compare the two
stocking lengths: using both standard meta-analysis and
network meta-analysis. Network meta-analysis enables a
comparison of all relevant treatments with one another.
This review was undertaken as part of a larger research
project to establish the expected value
(cost-effectiveness) of undertaking additional research
comparing the relative effectiveness of the two different
lengths of stocking, in addition to standard
pharmacoprophylaxis.7
METHODS
We conducted a systematic review to assess the clinical
effectiveness of thigh length versus knee length antiem-
bolism stockings for the prevention of DVT in surgical
patients. Owing to the anticipated paucity of research
evidence directly comparing thigh length stockings with
knee length stockings, we also sought studies comparing
thigh length stockings with a control treatment and
studies comparing knee length stockings with a control
treatment.
Clinical advice was provided by an advisory group
which included a vascular surgeon, an orthopaedic
surgeon and an anticoagulant and thrombosis
consultant nurse. A patient representative also provided
information on her experiences of using antiembolism
stockings after two different types of surgery.
The research protocol was registered on the inter-
national prospective register of systematic reviews
(PROSPERO registration number: CRD42014007202).
Search strategy
Eleven guideline and systematic review databases (includ-
ing the Cochrane Database of Systematic Reviews,
Database of Abstracts of Reviews of Effects, PROSPERO,
Health Technology Assessment Database and National
Guidelines Clearinghouse) were searched up to August
2013 for reviews of antiembolism stockings. The included
and excluded studies listed by relevant systematic reviews
were screened for relevant primary studies. To update the
searches undertaken in the relevant reviews, systematic
searches for RCTs published since January 2010 were
undertaken in February 2014. Six electronic sources were
searched (MEDLINE, MEDLINE In-Process, EMBASE,
CINAHL, AMED and CENTRAL) as well as two grey lit-
erature databases (ClinicalTrials.gov and Current
Controlled Trials). No language restrictions were applied.
In addition, clinical advisors were consulted for add-
itional potentially relevant studies and reference lists of
all included studies were manually searched. Records
were inserted into an EndNote library.
The search strategy developed for Ovid MEDLINE is
presented below.
Ovid MEDLINE(R) In-Process & Other Non-Indexed
Citations and Ovid MEDLINE(R), 1946 to Present.
Searched on 19 February 2014. Date limited to 2010
onwards. Search strategy:
1. exp “embolism and thrombosis”/ (172610)
2. (thrombos$ or thrombus$ or thrombotic or throm-
bolic$ or thromboemboli$ or thromboprophyla$ or
embol$).ti,ab. (232741)
3. (DVT$ or PE or PTS).ti,ab. (34899)
4. 1 or 2 or 3 (317779)
5. Stockings, Compression/ or Compression
Bandages/ (1165)
6. (stocking$ or hose or hosiery or tights or sock$ or
TEDS).ti,ab. (10451)
7. (compression adj3 bandage$).ti,ab. (486)
8. 5 or 6 or 7 (11541)
9. 4 and 8 (1418)
10. randomized controlled trial.pt. (362662)
11. controlled clinical trial.pt. (87530)
12. randomized.ab. (282970)
13. placebo.ab. (149727)
14. drug therapy.fs. (1661607)
15. randomly.ab. (205717)
16. trial.ab. (291784)
17. groups.ab. (1315795)
18. 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17
(3250729)
19. 9 and 18 (518)
20. limit 19 to yr=“2010 -Current” (141).
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Study selection
RCTs assessing thigh length or knee length antiembo-
lism stockings (with or without standard pharmaco-
logical prophylaxis) in surgical patients were eligible for
inclusion; the length of stocking had to be clearly stated.
The primary outcome was incidence of DVT; DVT data
were included only if deﬁnitively diagnosed using radio-
iodine (125I) ﬁbrinogen uptake, venography, Doppler
ultrasound or MRI. Studies reporting complications and
consequences associated with DVT (such as the inci-
dence of PE, incidence of post-thrombotic syndrome
and mortality) or adverse effects related to the use of
antiembolism stockings were also included.
Studies identiﬁed by the searches were independently
assessed for inclusion by two reviewers using the prespe-
ciﬁed inclusion criteria stated above. Disagreements
were resolved through discussion and, where necessary,
by consultation with a third reviewer.
Data extraction
Data extraction was conducted by one reviewer using a
piloted and standardised data extraction form in
Eppi-Reviewer 4.0 and independently checked by a
second reviewer. Discrepancies were resolved by discus-
sion, with involvement of a third reviewer when neces-
sary. In cases where the same study was reported in
multiple publications, the most up to date or compre-
hensive publication was used for data extraction. Data
were extracted on study details (eg, author, year, location
of study), patient characteristics (eg, age, gender, type of
surgery, baseline risk factors for VTE), details of the
intervention (eg, type of stocking, duration of use,
co-interventions including pharmacological thrombopro-
phylaxis), and reported outcomes (eg, method of assess-
ment and results).
Quality assessment
The quality of the individual trials was assessed by one
reviewer, and independently checked by a second
reviewer; disagreements were resolved by consensus and
if necessary a third reviewer was consulted. The quality of
included trials was assessed using the Cochrane Risk of
Bias Tool, which assesses methods of randomisation and
allocation concealment, blinding, completeness of
outcome data and selective outcome reporting.8
Similarity of treatment groups at baseline was also
assessed. Each trial was given an overall risk of bias judge-
ment; trials that had a low risk of bias for all key domains
were judged to have a low overall risk of bias, trials that
had a high risk of bias for one or more key domains were
judged to have a high overall risk of bias, and trials that
had an unclear risk of bias for one or more key domains
were judged to have an unclear overall risk of bias.
Synthesis
Analysis of the DVT data was performed using ORs
along with 95%CIs. Owing to the clinical and methodo-
logical variation between trials a random effects model
was used to pool data. The I2 statistic was used to quan-
tify statistical heterogeneity. The statistical package used
for analysis was RevMan V.5.2.
A network meta-analysis (NMA) was performed to
investigate whether the utilisation of indirect evidence
would increase the precision of the relative effect esti-
mate for thigh length versus knee length stockings. It
also provides an estimate of the relative effect of all treat-
ments relative to one another. A high level of inconsist-
ency between the direct and indirect evidence suggests
clinical or methodological heterogeneity, which
increases the uncertainty in the effect estimates.
Although several outcomes were investigated in the
review, there was only sufﬁcient evidence to perform an
NMA for the outcome DVT. To create the network,
interventions that were considered sufﬁciently similar
relative to the interventions of interest were lumped
together: the effectiveness of LMWH, low dose heparin
and fondaparinux were assumed to be the same, and
these were therefore lumped together in the network
and were referred to collectively as ‘heparin’. Based on
the advice of the clinical advisors, it was assumed that
there was no stocking-heparin interaction in the base
case analysis, that is, the effect of thigh length stockings
compared to knee length stockings is the same as thigh
length stockings plus concomitant heparin compared to
knee length stockings plus concomitant heparin. This
assumption was tested in a sensitivity analysis. A random
effects analysis was used and credible intervals (CrI) rep-
resent the uncertainty around the average treatment
effect across trials. The only potential effect modiﬁer for
which there was evidence across the trials and a relevant
network, was whether or not patients had undergone
orthopaedic surgery, which carries a high risk of DVT.
Therefore, a subgroup analysis was conducted to
compare the effectiveness of antiembolism stockings in
orthopaedic surgery patients versus other surgery
patients. The model, written in WinBUGS, was based on
code presented in the NICE Technical Support
Document 2.9
Data on the incidence of PE, mortality and adverse
events related to the use of antiembolism stockings were
tabulated and synthesised narratively.
RESULTS
During protocol development, scoping searches identi-
ﬁed two particularly relevant Cochrane reviews.10 11
Therefore, many relevant trials were identiﬁed from the
included and excluded studies lists of these reviews
(among others), prior to running the update searches
for primary studies.
The electronic search of the relevant systematic review
and guideline databases identiﬁed 307 records, of which
12 appeared to be systematic reviews of antiembolism
stockings in postoperative surgical patients (including the
two reviews identiﬁed during the protocol development
stage). These reviews were obtained so that their lists of
Wade R, et al. BMJ Open 2016;6:e009456. doi:10.1136/bmjopen-2015-009456 3
Open Access
group.bmj.com on April 1, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
included and excluded studies could be systematically
searched for potentially relevant primary studies. A total
of 137 records were added to the EndNote library from
the included and excluded studies lists of the 12 relevant
systematic reviews (after removal of duplicates). The
update searches of electronic databases (from 2010 to
February 2014) identiﬁed an additional 330 records,
which were also added to the EndNote library.
The full papers of 68 potentially relevant primary
studies were screened for inclusion in the review.
Twenty-three RCTs met the inclusion criteria and were
included in the systematic review (see online supplemen-
tary tables S1–5 for study details).12–34 Figure 1 presents
the ﬂow of studies through the study selection process.
Of these 23 RCTs, 21 reported data for the outcome
DVT. However, one trial did not report sufﬁcient data to
be included in the meta-analysis or NMA, as total
numbers of patients in treatment groups were not
reported.34 Figure 2 shows the network of 20 trials that
presented adequate data on DVT.
Seven trials did not add to the network of evidence
comparing thigh length with knee length antiembolism
stockings: these trials compared thigh length or knee
length stockings with a different intervention, such as
pneumatic compression or dextran.14 16 19 24 27 28 31
Both thigh length stockings and knee length stockings
needed to be compared with a common comparator to
be able to inform the relative effectiveness of the two dif-
ferent stocking lengths. Therefore, 13 RCTs contained
data that directly or indirectly informed the relative
effectiveness of thigh length versus knee length stock-
ings and were included in the standard meta-analysis or
NMA or both.12 13 15 17 18 20–23 25 29 32 33
There was substantial variation between the 23
included trials in terms of the patient characteristics,
suggesting that the participants had a different baseline
risk for DVT. There was also variation in the interven-
tions used in the RCTs; in some trials a stocking was
only worn on one leg, rather than both legs, and the
duration of use varied between trials. Concomitant
pharmacological prophylaxis also varied between trials.
Generally the trial methods were poorly reported, with
a high proportion of assessments for each quality
domain having to be recorded as unclear. Overall 3
RCTs can be considered to have a low risk of bias,14 23 25
5 have a high risk of bias18 22 27 32 33 and for 15 RCTs
the reporting was inadequate to judge the risk of
bias.12 13 15–17 19–21 24 26 28–31 34
Many of the included RCTs dated back to the
1970s13 19 and 1980s,14 16–18 20 22 24 26–31 33 therefore,
their results may not be generalisable to current prac-
tice; surgical practice has changed over time with less
invasive surgical procedures, shorter duration of hospi-
talisation and earlier mobilisation after surgery.
DVT results
Twenty RCTs reported rates of DVT and provided sufﬁ-
cient data to be included in meta-analyses. Where
reported, the majority of DVTs were asymptomatic, the
clinical consequences of which are unknown.
Thigh length stockings (with or without pharmacological
prophylaxis) versus knee length stockings (with or without
pharmacological prophylaxis)
Two RCTs12 25 directly compared thigh length versus
knee length stockings, plus pharmacological prophy-
laxis, reﬂecting current practice for the treatment of
patients at high risk of DVT; the results were inconsistent
in terms of the direction of effect. The reasons for the
inconsistent ﬁndings between the two trials were unclear
and may be due to chance.
Four additional RCTs that compared thigh length
versus knee length stockings were identiﬁed, but these
trials did not include additional pharmacological
prophylaxis.29 32–34 Unfortunately, the trial by Ayhan
(2013) was reported only as an abstract and did not
provide details on the number of patients in each treat-
ment group; therefore this trial was excluded from
meta-analyses.34
The ﬁve available RCTs comparing thigh length versus
knee length stockings with or without additional
pharmacological prophylaxis were combined using
meta-analysis (ﬁgure 3); the summary estimate of effect
indicated a trend favouring thigh length stockings, but
the ﬁndings were not statistically signiﬁcant (knee vs
thigh OR 1.48, 95% CI 0.80 to 2.73, p=0.21; I2=33%).
There was some inconsistency in the direction of
effect for trials assessing patients in similar surgical
groups. Cohen et al25 and Hui et al 32 included ortho-
paedic patients, and Porteous et al29 and Williams et al33
included patients undergoing abdominal surgery. The
reasons for the inconsistency were unclear and may be
due to chance.
The other 15 RCTs that reported DVT results com-
pared either thigh length or knee length antiembolism
stockings with no stocking or with another method of
thromboprophylaxis, therefore their results do not dir-
ectly inform the comparison of thigh versus knee length
stockings.
Network meta-analysis
Thirteen trials contained data that directly or indirectly
informed the relative effectiveness of thigh length versus
knee length stockings with or without pharmacological
prophylaxis for the prevention of DVT and were
included in the NMA. Table 1 presents the direct com-
parisons included in the NMA, and the number of
studies reporting that direct comparison. The number
of direct comparisons, 19, is greater than the number of
studies in the NMA because three three-armed trials
were included in the analysis.
The results of the NMA are the estimates of the
average effects across a heterogeneous set of trials.
The credible intervals (CrI) presented represent the
uncertainty around that average. There was signiﬁcant
statistical heterogeneity in the models and inconsistency
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indicating that there may be underlying unknown clin-
ical and methodological heterogeneity across the trials.
The results of the base case analysis found that
heparin was statistically signiﬁcantly more effective than
no treatment (median OR 0.26, 95% CrI 0.09 to 0.87,
p=0.03), thigh length stockings with heparin were statis-
tically signiﬁcantly more effective than heparin alone
(median OR 0.38, 95% CrI 0.21 to 0.63, p=0.00) and
knee length stockings with heparin were more effective
than heparin alone, although this result was not statistic-
ally signiﬁcant (median OR 0.68, 95% CrI 0.27 to 1.38,
p=0.28).
In the base case analysis, thigh length stockings with
pharmacological prophylaxis were more effective than
knee length stockings with pharmacological prophylaxis
(knee vs thigh OR 1.76, 95% CrI 0.82 to 3.53, p=0.12),
but this result was not statistically signiﬁcant. The indir-
ect estimate favours thigh length stockings slightly more
than the direct estimate of 1.48 (95% CI 0.80 to 2.73,
p=0.21) from the direct meta-analysis presented above,
but there is also greater uncertainty in the estimate. The
NMA did not increase the precision of the relative effect
estimate for thigh length versus knee length stockings
because of the uncertainty associated with the inconsist-
ency between direct and indirect estimates of effect. The
full table of results in the base case are presented in
online supplementary table S6.
The effectiveness of each treatment is represented by
the absolute risk of DVT in table 2. The baseline risk of
DVT (both symptomatic and asymptomatic) for
Figure 1 Flow diagram of the
study selection process. DVT,
deep vein thrombosis; NMA,
network meta-analysis; RCT,
randomised controlled trial.
Wade R, et al. BMJ Open 2016;6:e009456. doi:10.1136/bmjopen-2015-009456 5
Open Access
group.bmj.com on April 1, 2016 - Published by http://bmjopen.bmj.com/Downloaded from 
moderate risk general surgical patients taking heparin
was estimated to be 9.88%, estimated using the
American College of Chest Physicians Guidelines for the
prevention of VTE in non-orthopaedic surgical
patients.35 Using this baseline risk estimate, the absolute
risks of DVT for patients using the different treatments
are presented below in table 2. The combination of
thigh length stockings with pharmacological prophylaxis
Figure 2 Network of trials presenting data on DVT. DVT, deep vein thrombosis; LMWH, low-molecular-weight heparin; NHS,
National Health Service; NMA, network meta-analysis.
Figure 3 Rates of DVT (or VTE) comparing thigh length stockings (with or without pharmacological prophylaxis) versus knee
length stockings (with or without pharmacological prophylaxis). DVT, deep vein thrombosis; VTE, venous thromboembolism.
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was the most effective treatment with an absolute risk of
DVT of 4.04%. The probability that thigh length stock-
ings with pharmacological prophylaxis is the most effect-
ive treatment in a new trial of all the treatments is 73%,
as displayed in table 2. The probability of being the
most effective treatment does not simply reﬂect the
effectiveness of the treatment, but also the uncertainty
in the estimate. While thigh length stockings plus
pharmacological prophylaxis appear to be the most
effective treatment with little uncertainty, the marginal
beneﬁt of thigh length stockings plus heparin over
heparin alone is less than the marginal beneﬁt of
heparin over no treatment as heparin has already
reduced the risk of DVT substantially.
The sensitivity analysis modelling an interaction
between thigh or knee length stockings and heparin
produced results with the same direction of effect but
greater uncertainty in the effect estimate (knee vs thigh
OR 2.59, CrI 0.92 to 7.84, p=0.10). The subgroup ana-
lysis suggested that thigh length stockings with heparin
appear to be more effective in the non-orthopaedic
surgery group than in the orthopaedic surgery group.
The median ORs are slightly more in favour of both
thigh and knee length stockings with heparin compared
to heparin alone for the non-orthopaedic surgery group
(thigh: median OR 3.83, 95% CrI 2.29 to 6.66, p=0.00;
knee: median OR 2.16, 95% CrI 0.90 to 5.21, p=0.09)
compared to the orthopaedic surgery group (thigh:
median OR 2.05, 95% CrI 1.32 to 3.23, p=0.00; knee:
median OR 1.32, 95% CrI 0.72 to 2.46, p=0.37).
PE, mortality and adverse event results
Fifteen RCTs assessed PE or fatal PE, 11 RCTs assessed
mortality and 12 RCTs reported results relating to
adverse events. PE events and VTE-related deaths were
generally rare in the included trials. Adverse events were
rarely reported and those related to antiembolism stock-
ings were minor events, including minor foot abrasions,
superﬁcial thrombophlebitis or the stocking slipping
down. The majority of complications reported were
minor bleeding complications associated with pharmaco-
prophylaxis, although the proportion of patients report-
ing such events was low; between 1% and 4%.
DISCUSSION
This systematic review assessed the clinical effectiveness
of thigh length versus knee length antiembolism stock-
ings for the prevention of DVT in surgical patients. The
review only included studies of surgical patients; there-
fore, the results are not generalisable to other patient
populations, who may have a different baseline risk of
DVT and of the adverse effects of thromboprophylaxis.
Patients with stroke have been investigated separately in
a large RCT of thigh length versus knee length antiem-
bolism stockings, which found that DVT occurred more
often in patients who wore knee length stockings than
those who wore thigh length stockings.36
A previous Cochrane review comparing knee length
versus thigh length antiembolism stockings in post-
operative surgical patients included three of the ﬁve
RCTs included in our direct meta-analysis.11 The
Cochrane review also found no statistically signiﬁcant dif-
ference in clinical effectiveness between the two stocking
lengths in terms of reducing the incidence of DVT. The
authors concluded that there was insufﬁcient high
quality evidence to determine whether thigh length or
knee length stockings differ in their effectiveness in
terms of reducing the incidence of DVT in hospital in
patients.
Our systematic review included a network
meta-analysis of all the trials that indirectly informed the
relative effectiveness of thigh length versus knee length
antiembolism stockings, with or without pharmaco-
logical prophylaxis, for the prevention of DVT in surgi-
cal patients. The results of the NMA were consistent with
the direct meta-analysis, without increasing the precision
of the estimates. Overall, thigh length stockings with
pharmacological prophylaxis appears to be the most
Table 1 The direct comparisons included in the network
meta-analysis, and the number of studies reporting that
direct comparison
Treatment
Knee
length
stocking
No
prophylaxis
Knee
length
stocking
plus
heparin Heparin
Thigh length
stocking
3 4 1 1
Knee length
stocking
1 1 –
Thigh length
stocking plus
heparin
2 5
Knee length
stocking plus
heparin
1
Table 2 Probability of being the most effective treatment
in a new trial of all treatments
Treatment
Probability of
being the most
effective
treatment
Absolute
risk of DVT
(%)
No treatment 0.00 29.28
Thigh length stocking 0.04 13.76
Knee length stocking 0.02 22.01
Heparin 0.02 9.88
Thigh length stocking
plus heparin
0.73 4.04
Knee length stocking
plus heparin
0.20 6.94
DVT, deep vein thrombosis.
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effective method of preventing DVT in surgical patients,
the NMA results also indicate that the marginal beneﬁt
of thigh length stockings plus heparin over heparin
alone is less than the marginal beneﬁt of heparin over
no treatment, as heparin already reduces the risk of
DVT substantially.
Evidence relating to other outcomes was sparse; few
trials reported complications and consequences asso-
ciated with DVT, such as the incidence of PE, post-
thrombotic syndrome and mortality or adverse effects.
Despite the weak evidence base and importance of the
question, it is unlikely to be worthwhile undertaking a
new deﬁnitive trial comparing thigh length versus knee
length antiembolism stockings. Such a trial would need
to be very large to enable assessment of clinically rele-
vant DVT and its associated complications and conse-
quences in the relevant population, and should include
an assessment of patient adherence, both in hospital
and after patients have been discharged home. Such a
trial would therefore, be very costly to run. In addition,
while thigh length stockings appear to have superior efﬁ-
cacy, practical issues may prevent their wide use in clin-
ical practice; patients report that both thigh length and
knee length stockings are difﬁcult to use, but fewer
patients report discomfort with knee length stockings
and patients are more likely to wear knee length stock-
ings correctly.3–5 A more pragmatic approach may be to
give thigh length stockings only to patients who can use
them properly and consistently, while knee length stock-
ings are more appropriate for others.
Limitations
There was substantial variation across the included trials
in terms of the patient characteristics (suggesting that
the participants had a different baseline risk for DVT)
and interventions used (in terms of both stocking use
and concomitant pharmacological prophylaxis). The
timing of outcome assessments was generally short,
where reported; therefore some DVTs may have been
missed. The included trials assessed all DVTs, not just
symptomatic DVTs; where reported the majority of DVTs
were asymptomatic, the clinical consequences of which
are unknown.
Many of the included trials dated back to the 1970s
and 1980s, therefore, they may not reﬂect current prac-
tice: surgical practice has changed over time with less
invasive surgical procedures, shorter duration of hospi-
talisation and earlier mobilisation after surgery.
Generally the trial methods were poorly reported,
making risk of bias assessment difﬁcult. Only three out
of 23 included RCTs were considered to have a low risk
of bias; the reporting was inadequate to judge the risk of
bias for most trials. This systematic review included all
relevant trials, regardless of trial quality; therefore, the
uncertain quality of many of the included trials reduces
the reliability of the results of this review.
Conclusions
The evidence base for assessing the relative treatment
effectiveness of thigh length and knee length antiembo-
lism stockings for the prevention of DVT in surgical
patients is weak; most studies are old and may not
reﬂect current practice.
However, direct and indirect meta-analysis suggests
that thigh length stockings may be more effective than
knee length stockings, although the results were not stat-
istically signiﬁcant. Overall, thigh length stockings with
pharmacological prophylaxis appears to be the most
effective method of preventing DVT in surgical patients,
although the marginal beneﬁt of thigh-length stockings
plus heparin over heparin alone is less than the mar-
ginal beneﬁt of heparin over no treatment as heparin
already reduces the risk of DVT substantially.
Recommendations
Thigh length antiembolism stockings may be more
effective than knee length stockings at DVT prevention
in surgical patients; however, much of the available
research evidence is old and of uncertain quality. A
deﬁnitive trial in high risk surgical patients to compare
thigh length versus knee length antiembolism stockings,
in addition to standard pharmacological prophylaxis,
would need to be very large to enable assessment of clin-
ically relevant DVT and its associated complications and
consequences. Therefore, such a trial would be very
costly to run and it is not clear that it would be worth-
while. A more pragmatic approach may be to give thigh
length stockings only to patients who can use them
properly and consistently, while knee length stockings
are more appropriate for patients who are less physically
adept or likely to be less compliant.
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